Enter your login e-mail to the account
Search
- Prostate cancer – interaction potential of used drugs
PharmDr. Roman Goněc, PharmDr. Vojtěch Ondra, Doc. PharmDr. Jan Juřica, Ph.D.
(2/2025, Drug interaction )
- Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - The role of PARP inhibitors in the treatment of ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2021, Main topic ) - Current options for the use of PARP inhibitors in patients with metastatic castration-resistant prostate cancer with impaired DNA repair mechanisms
MUDr. Radovan Barila, PhD.
(3/2025, Review articles )













